BJMO - 2019, issue 2, february 2019
Bert Van Den Heuvel
To explore the clinical impact of FU-FDG-PET/CT in patients with LA-HNSCC treated with CRT or ST.
Real-life scan reports of LA-HNSCC patients having FU-FDG-PET/CT performed 6-18 months after ST/CRT were retrospectively analyzed. Equivocal reports were scored as positive. Excluded were patients with histological proof of recurrence before FU-FDG-PET/CT. The reference standard was the occurrence of a second primary (SP) or a recurrence within 12 months after FU-FDG-PET/CT. Primary endpoints included sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) on a patient level.
Between 7/10/2005 and 28/10/2016, 73 patients were identified: median age 61 (range 35-80), male: n=55. Primary tumor site: oropharynx: n=35; larynx: n=17; hypopharynx: n=11; oral cavity: n=4; paranasal sinus: n=4; unknown: n=5. Tumor stage (UICC 7): II (T2N0): n=1; III: n=9; IV: n=63. T1: n=8; T2: n=20; T3: n=16; T4: n=24; NO: n=10; N1: n=7; N2: n=53; N3: n=3. Patients were treated by CRT (n=29), IC + CRT (n=43), IC + RT (n=1). Median time between end of treatment and FU-FDG-PET/CT was 12 months (range 6-17). Median follow-up after FU-FDG-PET/CT was 48 months (range 2-130). Sensitivity, specificity, PPV and NPV were 83% (95% CI 52-98), 87% (95% CI 76-94), 56% (95% CI 31-78) and 96% (95% CI 87-100), respectively. Local recurrences, SPs and distant metastases were detected in 5, 1, 4 patients, respectively. 18 patients (25%) recurred after a false positive (n=8), false negative (n=2) or true negative (n=53) FU-FDG-PET-CT. One FU-FDG-PET/CT-detected local recurrence and one SP were treated with curative intent. All false-positive patients underwent biopsy (n=5) or surgery (n=3). Metastases were irradiated stereotactically in 2 patients. Median overall survival was 49 (95% CI 29 – 68) and 98 (95% CI 86-111) months in FU-FDG-PET/CT-positive and -negative patients, respectively (p = 0,000196).
FU-FDG-PET/CT in real-life has a high NPV, but low PPV. Prognostic value is significant but false-positive FU-FDG-PET/CTs induce invasive procedures in a significant fraction of patients.
Read more
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
